drugset / Trial / NCT00781339

Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients

NCT00781339 ↗

Phase 2 Completed 20 enrolled NovaBay Pharmaceuticals, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this clinical trial is to study the effects of NVC-422 instilled into the bladder in reducing bacteria in the urine.

Timeline

Start
2008-10
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate Unknown 0.1 % Other
Subject sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate Unknown 0.2 % Other

Indications